SCHEMBL4739495

SCHEMBL4739495

CC(C)OC1CC[C@@]2(C)C(CC[C@H]3[C@@H]4CC[C@H]([C@H](C)CC[C@H](C)C(C)C)[C@@]4(C)CC[C@@H]32)C1

nearest known ligand 0.57

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ VDR P11473 3/20 0.57
▸ USP2 O75604 1/20 0.57
▸ CDC25A P30304 2/20 0.56
▸ ABCC4 O15439 1/20 0.56
▸ POLA1 P09884 1/20 0.56
▸ ST6GAL1 P15907 2/20 0.55
▸ CYP2D6 P10635 1/20 0.53
▸ CYP2C19 P33261 1/20 0.53
▸ INPP5D Q92835 1/20 0.53
▸ GRIN1 Q05586 1/20 0.52
▸ GRIN2B Q13224 1/20 0.52
▸ TP53 P04637 1/20 0.52
▸ MAPK1 P28482 1/20 0.52
▸ CASP7 P55210 1/20 0.52
▸ HSD17B10 Q99714 1/20 0.52
▸ GPBAR1 Q8TDU6 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4735308 0.90 VDR (0.58) VDRUSP2CDC25AABCC4POLA1
SCHEMBL4739235 0.89 CDC25A (0.61) VDRUSP2CDC25AABCC4POLA1
SCHEMBL21928679 0.89 VDR (0.60) VDRUSP2CDC25AABCC4POLA1
SCHEMBL4738650 0.89 VDR (0.55) VDRUSP2CDC25AABCC4POLA1
SCHEMBL4739418 0.87 CDC25A (0.61) VDRUSP2CDC25AABCC4POLA1
SCHEMBL4740584 0.87 VDR (0.56) VDRUSP2CDC25AABCC4POLA1
SCHEMBL4735713 0.87 CDC25A (0.73) VDRUSP2CDC25AABCC4POLA1
SCHEMBL19430789 0.87 CDC25A (0.73) VDRUSP2CDC25AABCC4POLA1
SCHEMBL14601433 0.87 CDC25A (0.73) VDRUSP2CDC25AABCC4POLA1
SCHEMBL24015459 0.86 VDR (0.57) VDRUSP2CDC25AABCC4POLA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008077247-A1 COATINGS FOR IMPLANTABLE MEDICAL DEVICES COMPRISING CHOLESTEROL MIV THERAPEUTICS INC. (CA) 2008-07-03 — — WO disclosed
Send feedback